Cited by 129Infective Endocarditis Diagnosis and ManagementCardiac Valve Diseases and TreatmentsStreptococcal Infections and Treatments

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Increasing US Rates of <emph type="ital" /> Endocarditis With <emph type="ital">Staphylococcus aureus</emph>: 1999-2008

Open access

Federspiel, Jerome J.·2012·Archives of Internal Medicine

DOI 10.1001/archinternmed.2011.1027PMC PMC3314241

Open this paper in CoChat — free account Open PDF

Abstract

Estimates of the incidence and impact of bacterial infective endocarditis (IE) have been limited by the infrequency of the disease. Administrative data analyses can provide important information across a broad range of hospitals and regions. We used a recent, nationally representative sample to estimate the incidence of hospitalizations for bacterial IE in the United States.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/archinternmed.2011.1027

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Kim H‐J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351
Kim, H. (2001) · Statistics in Medicine · doi:10.1002/sim.811 · Cited by 885
A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario
Austin, P. C., Daly, P. A., & Tu, J. V. (2002) · American Heart Journal · doi:10.1067/mhj.2002.123839 · Cited by 524
Increasing rates of cardiac device infections among medicare beneficiaries: 1990–1999
Cabell, C. H., Heidenreich, P. A., Chu, V. H. Y., Moore, C. M., Stryjewski, M. E., Corey, G. R., & Fowler, V. G. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.06.005 · Cited by 393
Temporal Trends in Infective Endocarditis
Tleyjeh, I. M., Steckelberg, J. M., Murad, H. S., Anavekar, N. S., Ghomrawi, H., Mirzoyev, Z., Moustafa, S., Hoskin, T. L., Mandrekar, J. N., Wilson, W. R., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3022 · Cited by 361
The Burden of Staphylococcus aureus Infections on Hospitals in the United States
Noskin, G. A., Rubin, R. J., Schentag, J. J., Kluytmans, J. A. J. W., Hedblom, E. C., Smulders, M., Lapetina, E. M., & Gemmen, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.15.1756 · Cited by 301
Influence of referral bias on the apparent clinical spectrum of infective endocarditis
Steckelberg, J. M., Rouse, M. S., Wilson, W. R., Melton, L. J., & Ilstrup, D. M. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90521-e · Cited by 206
Veteran’s affairs hospital discharge databases coded serious bacterial infections accurately
Schneeweiss, S., Robicsek, A., Scranton, R., Zuckerman, D., & Solomon, D. H. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.07.011 · Cited by 178
Bootstrap confidence intervals for the sensitivity of a quantitative diagnostic test
Platt, R. W., Hanley, J. A., & Yang, H. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3 · Cited by 83
Temporal Trends in Infective Endocarditis: A Population-based Study in Olmsted County, Minnesota
Tleyjeh, I. M., Steckelberg, J. M., & Murad, H. S. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.08.194 · Cited by 35

Show all 9 references

Sorted by citations

Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
“United States suggest that rates of S aureus IE have increased significantly relative to other causes of IE.(3) This increase is”
Background
Challenges in Infective Endocarditis
Cahill, T. J., Baddour, L. M., Habib, G., Hoen, B., Salaün, E., Pettersson, G., Schäfers, H., & Prendergast, B. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.066 · Cited by 724
Infective Endocarditis
Hoen, B., & Duval, X. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1206782 · Cited by 518
Infective Endocarditis Epidemiology Over Five Decades: A Systematic Review
Slipczuk, L. N., Codolosa, J. N., Davila, C. D., Romero‐Corral, A., Yun, J. H., Pressman, G. S., & Figueredo, V. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082665 · Cited by 453
“Furthermore, at least when measured by ICD codes the total number of SA cases seems to be increasing in the US [15].”
Background
Infective endocarditis
Holland, T. L., Baddour, L. M., Bayer, A. S., Hoen, B., Miró, J. M., & Fowler, V. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.59 · Cited by 466
Mouse models for infectious diseases caused by Staphylococcus aureus
Kim, H. K., Missiakas, D. M., & Schneewind, O. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.04.007 · Cited by 187
Endocarditis and Intravascular Infections
Fowler, V. G., Scheld, W. M., & Bayer, A. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00082-5 · Cited by 144
Staphylococcus aureusbacteraemia and endocarditis – epidemiology and outcome: a review
Ásgeirsson, H., Thalme, A., & Weiland, O. (2017) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2017.1392039 · Cited by 142
“Similarly, an increase has been seen in the incidence of SAE over time (Figure 2) [5,65].”
Background
Expanded Glucose Import Capability Affords Staphylococcus aureus Optimized Glycolytic Flux during Infection
Vitko, N. P., Grosser, M. R., Khatri, D., Thurlow, L. R., & Richardson, A. R. (2016) · mBio · doi:10.1128/mbio.00296-16 · Cited by 140
Catheterization alters bladder ecology to potentiate Staphylococcus aureus infection of the urinary tract
Walker, J. N., Flores‐Mireles, A. L., Pinkner, C. L., Schreiber, H. L., Joens, M. S., Park, A. M., Potretzke, A. M., Bauman, T. M., Pinkner, J. S., Fitzpatrick, J. A. J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707572114 · Cited by 119
“Overall, CAUTI is the leading cause of secondary hospital-associated bloodstream infections (BSIs) (23), and MRSA BSIs are associated with high rates of morbidity and mortality, frequently resulting in metastatic infections of other organs and tissues, endocarditis, and septic shock (4, 8, 12, 18, 24, 25).”
Background
Staphyloxanthin: a potential target for antivirulence therapy
Xue, L., Chen, Y. Y., Yan, Z., Lu, W., Wan, D., & Zhu, H. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s193649 · Cited by 116
“Diseases caused by this bacterium are minor skin infections, pneumonia, sepsis, and endocarditis.(2,3) S.”
Background
A Nationwide Cohort Study of Mortality Risk and Long-Term Prognosis in Infective Endocarditis in Sweden
Ternhag, A., Cederström, A., Törner, A., & Westling, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067519 · Cited by 113
The increasing incidence of infective endocarditis in Denmark, 1994–2011
Erichsen, P., Gislason, G., & Bruun, N. E. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.05.021 · Cited by 76
Staphyloxanthin as a Potential Novel Target for Deciphering Promising Anti-Staphylococcus aureus Agents
Elmesseri, R. A., Saleh, S. E., Elsherif, H. M., Yahia, I. S., & Aboshanab, K. M. (2022) · Antibiotics · doi:10.3390/antibiotics11030298 · Cited by 66
Effect of Vancomycin Minimal Inhibitory Concentration on the Outcome of Methicillin-Susceptible Staphylococcus aureus Endocarditis
Cervera, C., Castaneda, X., de la Maria, C. G., del Rio, A., Moreno, A., Soy, D., Pericas, J. M., Falces, C., Armero, Y., Almela, M., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu183 · Cited by 61
Echocardiographic Findings Predict In-Hospital and 1-Year Mortality in Left-Sided Native Valve Staphylococcus aureus Endocarditis
Lauridsen, T. K., Park, L., Tong, S. Y. C., Selton‐Suty, C., Peterson, G., Cecchi, E., Afonso, L., Habib, G., Paré, C., Tamin, S. S., et al. (2015) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.114.003397 · Cited by 60
Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)
Gudiol, F., Aguado, J. M., Almirante, B., Bouza, E., Cercenado, E., Domínguez, M. Á., Gasch, O., Lora-Tamayo, J., Miró, J. M., Palomar, M., et al. (2015) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2015.03.015 · Cited by 59
Accuracy of administrative data for identification of patients with infective endocarditis
Tan, C., Hansen, M., Cohen, G. N., Boyle, K., Daneman, N., & Adhikari, N. K. J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.030 · Cited by 58
Infective endocarditis after device closure of atrial septal defects: Case report and review of the literature
Amédro, P., Soulatges, C., & Fraisse, A. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26784 · Cited by 55
Using Population Based Hospitalization Data to Monitor Increases in Conditions Causing Morbidity Among Persons Who Inject Drugs
Collier, M. G., Doshani, M., & Asher, A. K. (2018) · Journal of Community Health · doi:10.1007/s10900-017-0458-9 · Cited by 50
“IE rates increased among elderly patients with cardiac devices during 1998–2008 [13, 14], and has been increasing in recent years among PWID [15–17].”
Background
Temporal trends in incidence, patient characteristics, microbiology and in-hospital mortality in patients with infective endocarditis: a contemporary analysis of 86,469 cases between 2007 and 2019
Becher, P. M., Goßling, A., Fluschnik, N., Schrage, B., Seiffert, M., Schofer, N., Blankenberg, S., Kirchhof, P. F., Westermann, D., & Kalbacher, D. (2022) · Clinical Research in Cardiology · doi:10.1007/s00392-022-02100-4 · Cited by 48
Global proteome analysis of vancomycin stress in Staphylococcus aureus
Heßling, B., Bonn, F., Otto, A., Herbst, F., Rappen, G.-M., Bernhardt, J., Hecker, M., & Becher, D. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.08.014 · Cited by 47
Bacteremia, Sepsis, and Infective Endocarditis Associated with Staphylococcus aureus
Bergin, S. P., Holland, T. L., Fowler, V. G., & Tong, S. Y. C. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_5001 · Cited by 46
Mitral endocarditis: A new management framework
Nappi, F., Spadaccio, C., Dreyfus, J., Attias, D., Acar, C., & Bando, K. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.03.159 · Cited by 47
Staphylococcus aureus gene expression in a rat model of infective endocarditis
Hanses, F., Roux, C. M., Dunman, P. M., Salzberger, B., & Lee, J. C. (2014) · Genome Medicine · doi:10.1186/s13073-014-0093-3 · Cited by 45
“Staphylococcus aureus is the most frequent etiologic agent of endocarditis in developed countries [1,3] and is associated with an aggressive disease course, a poor outcome, and complications such as local destruction of valve tissue, septic emboli, and persistent bacteremia [3].”
Background
The “3M” Approach to Cardiovascular Infections: Multimodality, Multitracers, and Multidisciplinary
Sollini, M., Berchiolli, R. N., Bolton, R. C. D., Rossi, A., Kirienko, M., Boni, R., Lazzeri, E., Slart, R. H. J. A., & Erba, P. A. (2018) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2017.12.003 · Cited by 42
“Although the overall disease incidence has remained stable ranging annually from 3 to 7 per 100 000 person-years in the most contemporary population surveys (57-64), during the least years the epidemiology of IE has become more complex and the epidemiological profile has changed”
Background
S. aureus endocarditis: Clinical aspects and experimental approaches
Hoerr, V., Franz, M., Pletz, M. W., Diab, M., Niemann, S., Faber, C., Doenst, T., Schulze, P. C., Deinhardt‐Emmer, S., & Löffler, B. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2018.02.004 · Cited by 42
Clinical risk factors for acute ischaemic and haemorrhagic stroke in patients with infective endocarditis
Valenzuela, I. A., Hunter, M. D., Sundheim, K. M., Klein, B., Dunn, L. E., Sorabella, R. A., Han, S. M., Willey, J. Z., George, I., & Gutierrez, J. (2018) · Internal Medicine Journal · doi:10.1111/imj.13958 · Cited by 40
Molecular Imaging of Bacterial Infections in vivo: The Discrimination between Infection and Inflammation
Eggleston, H., & Panizzi, P. R. (2014) · Informatics · doi:10.3390/informatics1010072 · Cited by 37
Reverse-vaccinology strategy for designing T-cell epitope candidates for Staphylococcus aureus endocarditis vaccine
Oprea, M. M., & Antohe, F. (2013) · Biologicals · doi:10.1016/j.biologicals.2013.03.001 · Cited by 36
“aureus was isolated as the causative agent in 46% of 87,300 patients with EI investigated during 1999e2008 in US [5].”
Background
Secreted Immunomodulatory Proteins of Staphylococcus aureus Activate Platelets and Induce Platelet Aggregation
Binsker, U., Palankar, R., Wesche, J., Kohler, T. P., Prucha, J., Burchhardt, G., Rohde, M., Schmidt, F., Bröker, B. M., Mamat, U., et al. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1637735 · Cited by 34
Changing spectrum of infective endocarditis in India: An 11-year experience from an academic hospital in North India
Arora, N., Panda, P. K., Revaiah, P. C., Uppal, L., Saroch, A., Angrup, A., Sharma, N., Sharma, Y. P., Vijayvergiya, R., Rohit, M. K., et al. (2021) · Indian Heart Journal · doi:10.1016/j.ihj.2021.09.008 · Cited by 30
Surgical treatment of transcatheter aortic valve infective endocarditis
Malvindi, P. G., Luthra, S., Sarvananthan, S., Zingale, A., Olevano, C., & Ohri, S. K. (2020) · Netherlands Heart Journal · doi:10.1007/s12471-020-01494-y · Cited by 28
New insights into valve-related intramural and intracellular bacterial diversity in infective endocarditis
Oberbach, A., Schlichting, N. S., Feder, S., Lehmann, S., Kullnick, Y., Buschmann, T., Blumert, C., Horn, F., Neuhaus, J., Neujahr, R., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175569 · Cited by 28
Bacteriophage AB-SA01 Cocktail in Combination with Antibiotics against MRSA-VISA Strain in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Kebriaei, R., Lev, K. L., Stamper, K. C., Lehman, S. M., Morales, S., & Rybak, M. J. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01863-20 · Cited by 27
Long-term prognosis of left-sided native-valve Staphylococcus aureus endocarditis
Abdallah, L., Rémadi, J. P., Habib, G., Salaün, E., Casalta, J., & Tribouilloy, C. M. (2016) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2015.11.012 · Cited by 28
Percutaneous Mechanical Aspiration in Infective Endocarditis: Applications, Technical Considerations, and Future Directions
Sabbagh, A. E., Yucel, E., Zlotnick, D. M., Moriarty, J. M., Younes, S., Hamid, N. B., Akhtar, Y., Baddour, L. M., O’Gara, P. T., Starck, C. T., et al. (2024) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2023.101269 · Cited by 26
Are Sutureless Aortic Valves Suitable for Severe High-Risk Patients Suffering from Active Infective Aortic Valve Endocarditis?
Weymann, A., Konertz, J., Laule, M., Stangl, K., & Dohmen, P. M. (2017) · Medical Science Monitor · doi:10.12659/msm.902785 · Cited by 23
“As previously mentioned, today’s patients suffering from AIE are older and the proportion of patients with healthcare-associated AIE has increased to up to 30% of all active infective endocarditis patients [5,6].”
Background
Simplified risk stratification criteria for identification of patients with MRSA bacteremia at low risk of infective endocarditis: implications for avoiding routine transesophageal echocardiography in MRSA bacteremia
de la Vega, P. B., Tandon, P., Qureshi, W., Nasr, Y., Jayaprakash, R., Arshad, S., Moreno, D., Jacobsen, G., Ananthasubramaniam, K., Ramesh, M. S., et al. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2539-y · Cited by 22
Evolution of the Incidence, Mortality, and Cost of Infective Endocarditis in Spain Between 1997 and 2014
Heredia‐Rodríguez, M., Hernández, A., Bustamante‐Munguira, J., Alvarez, E., Bouza, J. M. E., Castrodeza, J., & Tamayo, E. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4514-7 · Cited by 22
Non-HACEK Gram-negative bacillus endocarditis
Mercan, M. E., Arslan, F., Alp, Ş., Atilla, A., Seyman, D., GULİYEVA, G., Kayaaslan, B., Sarı, S., Suntur, B. M., Isik, B., et al. (2019) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2019.03.013 · Cited by 22
Molecular Targets for Antibody-Based Anti-Biofilm Therapy in Infective Endocarditis
Han, J., & Poma, A. (2022) · Polymers · doi:10.3390/polym14153198 · Cited by 21
Surgery for acute infective endocarditis: epidemiological data from a Spanish nationwide hospital-based registry†
Bustamante‐Munguira, J., Mestres, C. A., Alvarez, P., Figuerola‐Tejerina, A., Bachiller, R. E., Gómez‐Sánchez, E., Alvarez, F. J., Resino, S., Castrodeza, J., & Tamayo, E. (2018) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivy127 · Cited by 21
Improving medical care and prevention in adults with congenital heart disease—reflections on a global problem—part II: infective endocarditis, pulmonary hypertension, pulmonary arterial hypertension and aortopathy
Neidenbach, R. C., Niwa, K., Oto, O., Oechslin, E. N., Aboulhosn, J., Celermajer, D. S., Schelling, J., Pieper, L., Sanftenberg, L., Oberhoffer, R., et al. (2018) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2018.10.16 · Cited by 21
Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study
Anantha, R. V., Jegatheswaran, J., Pepe, D., Priestap, F. A., Delport, J. A., Haeryfar, S. M. M., McCormick, J. K., & Mele, T. S. (2014) · CMAJ Open · doi:10.9778/cmajo.20140018 · Cited by 20
Device-related infective endocarditis, with special consideration of implanted intravascular and cardiac devices in a predominantly male population
Roig, I. L., Darouiche, R. O., Musher, D. M., & Trautner, B. W. (2012) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2012.678882 · Cited by 18
“While this certainly affects the ability to generalize from our fi ndings, a recent cohort study (using the Nationwide Inpatient Sample) of more than 80,000 hospital discharges with a diagnosis of IE showed that the majority of cases also involved Caucasian (71%) males (60%), suggesting a similar trend in centers outs…”
Result
Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience
Ásgeirsson, H., Thalme, A., Kristjánsson, M., & Weiland, O. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.04.014 · Cited by 18
“Staphylococcus aureus has become the leading cause of infective endocarditis (IE) in many regions of the world [1–5].”
BackgroundResult
Health Care-Associated Infective Endocarditis: a Growing Entity that Can Be Prevented
Benito, N., Pericàs, J. M., Gurguí, M., Mestres, C. A., Marco, F., Moreno, A., Horcajada, J. P., & Miró, J. M. (2014) · Current Infectious Disease Reports · doi:10.1007/s11908-014-0439-4 · Cited by 17
Outcome of Dialysis-Requiring Acute Kidney Injury in Patients With Infective Endocarditis: A Nationwide Study
Petersen, J. K., Jensen, A. D., Bruun, N. E., Kamper, A., Butt, J. H., Havers‐Borgersen, E., Chaudry, M. S., Torp-Pedersen, C. T., Køber, L., Fosbøl, E. L., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1017 · Cited by 15
Daily Administered Dual-Light Photodynamic Therapy Provides a Sustained Antibacterial Effect on Staphylococcus aureus
Nikinmaa, S., Podonyi, A., Raivio, P. M., Meurman, J. H., Sorsa, T. A., Rantala, J., Kankuri, E. M., Tauriainen, T., & Pätilä, T. (2021) · Antibiotics · doi:10.3390/antibiotics10101240 · Cited by 15
“aureus is the leading cause of infectious endocarditis [3,4].”
Background
Infective endocarditis in the setting of renal transplantation: Case report and review of the literature
Agmon, I. N., Goldberg, E., Cohen, E., & Krause, I. (2017) · Transplant Infectious Disease · doi:10.1111/tid.12786 · Cited by 14
Empyema Necessitans in the Setting of Methicillin-Susceptible Staphylococcus aureus Causing Pneumonia and Bacteremia
Bandaru, S., Manthri, S., Sundareshan, V., & Prakash, V. (2018) · Case Reports in Infectious Diseases · doi:10.1155/2018/4906547 · Cited by 13
Collaborative Cross mice have diverse phenotypic responses to infection with Methicillin-resistant Staphylococcus aureus USA300
Nagarajan, A., Scoggin, K., Gupta, J., Aminian, M., Adams, L. G., Kirby, M. J. L., Threadgill, D. W., & Andrews‐Polymenis, H. L. (2024) · PLoS Genetics · doi:10.1371/journal.pgen.1011229 · Cited by 12
“[104,105].”
Endocarditis: Who Is Particularly at Risk and Why? Ten Years Analysis of Risk Factors for In-hospital Mortality in Infective Endocarditis
Ostovar, R., Schroeter, F., Erb, M., Kuehnel, R.-U., Hartrumpf, M., & Albes, J. M. (2022) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-0042-1748950 · Cited by 12
Epidemiology of Infective Endocarditis
Vallejo, F. A. G. (2016) · InTech eBooks · doi:10.5772/65030 · Cited by 12
Current Evidence on Oral Antibiotics for Infective Endocarditis: A Narrative Review
Kobayashi, T., Ando, T., Streit, J. A., & Sekar, P. (2019) · Cardiology and Therapy · doi:10.1007/s40119-019-00148-4 · Cited by 11
Aerococcus Urinae Aortic Valve Endocarditis with Kissing Aortic Wall Ulcer: A Case Report and Literature Review
Ludhwani, D., Li, J. Y.-M., Huang, E. E., Sikora, A., & Thomas, G. W. (2020) · American Journal of Case Reports · doi:10.12659/ajcr.920974 · Cited by 11
“The 3 most frequently identified organisms implicated in IE are staphylococcus, followed by streptococcus and enterococcus [4,5].”
Background
Sharing of decision-making for infective endocarditis surgery: a narrative review of clinical and ethical implications
Pollari, F., Spadaccio, C., Cuomo, M., Chello, M., Nenna, A., Fischlein, T. J. M., & Nappi, F. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-4626 · Cited by 11
“At the same time the role of microbiologist is fundamental: for the correct diagnosis as well for orienting the appropriate antibiotic strategy (21,23,24).”
Background
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin
de la Mària, C. G., Cañas, M.-A., Fernández-Pittol, M., Dahl, A., García‐González, J., Hernández‐Meneses, M., Cuervo, G., Moreno, A., Miró, J. M., & Marco, F. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2174969 · Cited by 10
“burden of this disease is certainly increasing [16].”
Background
Isovanillic Acid Protects Mice Against Staphylococcus Aureus by Targeting vWbp and Coa
Chen, X., Hu, C., Shu, Z., Wang, X., Zhao, Y., Wu, S., Chen, X., Jin, M., Xiu, Y., Guo, X., et al. (2023) · Future Microbiology · doi:10.2217/fmb-2022-0219 · Cited by 9
Exploring links between oral health and infective endocarditis
Falconer, J. L., Rajani, R., Androshchuk, V., Yogarajah, A., Greenbury, R. A., Ismail, A., Oh, N., Nibali, L., D’Agostino, E. M., & Sousa, V. (2024) · Frontiers in Oral Health · doi:10.3389/froh.2024.1426903 · Cited by 9
Heart transplantation as salvage therapy for progressive prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis (MRSE)
Borde, J., Sitaru, G., Kopp, W. H., Ruhparwar, A., Ehlermann, P., Lasitschka, F., Dalpke, A. H., & Heininger, A. (2016) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-016-0505-0 · Cited by 9
Successful management of a complicated clinical crisis
Xu, P., Zeng, H., Zhou, M., Ouyang, J., Chen, B., & Zhang, Q. (2017) · Medicine · doi:10.1097/md.0000000000009451 · Cited by 9
Surgical treatment of infective endocarditis: Results in 831 patients from a single center
Kilic, A., Huckaby, L. V., Hong, Y., Sultan, I. S., Aranda-Michel, E. C., Thoma, F. W., Wang, Y., Navid, F., & Gleason, T. G. (2020) · Journal of Cardiac Surgery · doi:10.1111/jocs.14893 · Cited by 8
“1% increased adjusted risk of in‐hospital mortality.(12) As with all cardiac operations, accurate risk estimations are an important component of surgical decision‐making and patient prognostication.”
Background
Surgical Treatment of Active Endocarditis Pre- and Post-COVID-19 Pandemic Onset
Mikus, E., Fiorentino, M., Sangiorgi, D., Fiaschini, C., Tenti, E., Tremoli, E., Calvi, S., Costantino, A., Tripodi, A. G., Zucchetta, F., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12010233 · Cited by 8
Update on Antibiotic Prophylaxis for Genitourinary Procedures in Patients with Artificial Joint Replacement and Artificial Heart Valves
Mazur, D. J., Fuchs, D. J., Abicht, T. O., & Peabody, T. D. (2015) · Urologic Clinics of North America · doi:10.1016/j.ucl.2015.06.003 · Cited by 8
Clinical manifestations of infective endocarditis in relation to infectious agents: An 8-year retrospective study
Pazderník, M., Kautzner, J., SOCHMAN, J., Kettner, J., Vojáček, J., & Pelouch, R. (2016) · Biomedical Papers · doi:10.5507/bp.2015.062 · Cited by 7
Infective endocarditis and solid organ transplantation: Only worse outcomes during initial transplantation hospitalization
Eichenberger, E. M., Dagher, M. M., Sinclair, M. R., Maskarinec, S. A., Fowler, V. G., & Federspiel, J. J. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.06.007 · Cited by 7
Self-citation
Aortic root abscess from Enterococcus faecalis infective endocarditis: Case report and brief review of the literature
Hathaway, Q. A., Balar, A., Mallicoat, T. A., Voss, J. A., Amin, M. S., Lakhani, D. A., & Kim, C. (2022) · Radiology Case Reports · doi:10.1016/j.radcr.2022.08.011 · Cited by 5
“[10] Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG Jr.”
Background
Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia and Prosthetic Valve Endocarditis With Ceftaroline
Najjar, S., Biehle, L. R., Najjar, J., & Finkel, D. G. (2013) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e318287c73f · Cited by 5
“Over the last decade, Staphylococcus aureus (SA) has emerged as the leading cause of infective endocarditis in the United States.1 Endocarditis due to SA has been associated with a high probability of mortality, emphasizing the importance of effective treatment options.”
Background
Repair of infected mitral valves: what have we learned?
Hu, Y.-N., & Wan, S. (2018) · Surgery Today · doi:10.1007/s00595-018-1637-8 · Cited by 5
Infective Endocarditis: A Case Series
Singh, S. P., & Singh, D. (2020) · Journal of Cardiac Critical Care TSS · doi:10.1055/s-0040-1716610 · Cited by 5
Changing microbiological profile and antimicrobial susceptibility of the isolates obtained from patients with infective endocarditis – The time to relook into the therapeutic guidelines
Gupta, R., Kaushal, V., Goyal, A., Kumar, P., Gupta, D., Tandon, R., Mahajan, A., Singla, S., Singh, G., Singh, B., et al. (2021) · Indian Heart Journal · doi:10.1016/j.ihj.2021.10.013 · Cited by 5
Management of MRSA/GISA, VISA Endocarditis
Jacqueline, C., Caillon, J., & Boutoille, D. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0349-x · Cited by 4
Endocarditis infecciosa: experiencia de 10 años en un centro no cardiovascular
Ruiz-Beltrán, A. M., Barrón-Magdaleno, C., Ruiz-Beltran, S. M., Sánchez-Villa, J. D., Orihuela, C., Oseguera-Moguel, J., & Payró-Ramírez, G. (2021) · Archivos de cardiología de México · doi:10.24875/acm.20000467 · Cited by 4
Distant embolisation in infective endocarditis: characteristics and outcomes
Duffels, M. G. J., Germans, T., Bos-Schaap, A. J. C. M., Drexhage, O., Wagenaar, J. F. P., van der Zant, F. M., Hoogewerf, M., Knol, R. J. J., & Umans, V. A. W. M. (2023) · Netherlands Heart Journal · doi:10.1007/s12471-023-01771-6 · Cited by 4
Implementation of a Multidisciplinary Team–Based Clinical Care Pathway Is Associated With Increased Surgery Rates for Infective Endocarditis
Crosby, H. W. (2023) · Journal of clinical outcomes management · doi:10.12788/jcom.0125 · Cited by 4
Rapid Diagnostic Testing for Infective Endocarditis and Myocarditis Using Nanopore Targeted Sequencing
Fu, A., Wang, X., Shen, Z., Gu, J., Zhang, T., Wang, F., Jia, S., Yang, L., Li, F., Geng, J., et al. (2025) · iLABMED · doi:10.1002/ila2.70016 · Cited by 3
Aerococcus urinae tricuspid valve infective endocarditis
Banerjee, S., Murali, S., Azhar, A., Pathmanathan, A., & Chaudhuri, D. (2022) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2022.2054042 · Cited by 3
The role of cytokines in the pathogenesis of infective endocarditis
Kolesnikova, N. V., & Samoylenko, E. S. (2020) · Immunologiya · doi:10.33029/0206-4952-2020-41-3-262-268 · Cited by 3
Microbiology of Infective Endocarditis and Microbiologic Diagnosis
Skinner, S., Wudel, B., & Sanche, S. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-27784-4_4 · Cited by 3
Trends in Epidemiology: Analysis of Risk Factors and Outcomes of Infective Endocarditis. A Retrospective Study (2009–2015)
Lin, A., Kyaw, H., Lin, K., Pendharkar, S. S., Shaikh, A. Z., Ayala-Rodriguez, C. E., Abboud, J. A., & Reddy, S. (2019) · Cureus · doi:10.7759/cureus.3910 · Cited by 3
L’endocardite infectieuse au Maroc à travers l’expérience d’un service hospitalier
Harrak, S., Doghmi, N., Fellat, B., Zarzur, J., & Cherti, M. (2019) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2018.10.014 · Cited by 3
Antithrombotic Therapy for Stroke Patients with Cardiovascular Disease
Gusdon, A. M., Farrokh, S., & Grotta, J. C. (2021) · Seminars in Neurology · doi:10.1055/s-0041-1726331 · Cited by 4
Staphylococcus aureus infective endocarditis at a tertiary Tunisian hospital. A changing profile?
Drissa, M., Amani, F., & Drissa, H. (2018) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2018.09.001 · Cited by 3
“Fiederspiel et al.22 recently reported nearly a 60% increased risk of in-hospital mortality from SAIE compared with streptococcal and enterococcal endocarditis.”
Result
Staphylococcus aureus Bacteremia in Hospitalized Patients and Associated Factors: A Cross-sectional Study from Mashhad, Iran
Heydari, A. A., Eslami, A., & Dadgarmoghaddam, M. (2021) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.116313 · Cited by 2
Patient characteristics, valve surgery and 1-year mortality in left-sided Staphylococcus aureus infective endocarditis: a nationwide study
Nielsen, S. T., Graversen, P. L., Hadji-Turdeghal, K., Møller, J. E., Bruun, N. E., Jensen, A. D., Petersen, J. K., Povlsen, J. A., Moser, C. E., Smerup, M., et al. (2025) · Heart · doi:10.1136/heartjnl-2025-327031 · Cited by 2
Letter by Duval et al Regarding Article, “Incidence of Infective Endocarditis Caused by Viridans Group Streptococci Before and After Publication of the 2007 American Heart Association’s Endocarditis Prevention Guidelines”
Duval, X., Alla, F., & Hoen, B. (2013) · Circulation · doi:10.1161/circulationaha.112.135731 · Cited by 2
Infective endocarditis epidemiology over fi ve decades: a systematic review.
Slipczuk, L. N., Codolosa, J. N., & Davila, C. D. (2013) · The Medicine Forum · Cited by 2
Perivalvular Mitral Abscess Fistulised to the Pericardial Cavity Revealing Staphylococcal Endocarditis
Desaint, P., Chauvat, A., Garaud, T., Andremont, O., Plantefève, G., Mentec, H., & Contou, D. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.10.013 · Cited by 2
Evaluation of 99mTechnetium-Vancomycin Imaging Potential in Experimental Rat Model for the Diagnosis of Infective Endocarditis
Kış, T. T., Köse, Ş., Yılmaz, O., Kış, M., Yurt, F., Acar, E., Bekiş, R., Yılmaz, C., BARIŞ, M. M., Dınız, G., et al. (2020) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/1573405616666201229161850 · Cited by 2
Interventricular Septum Abscess
Sattar, Y., & Widrich, J. (2019) · StatPearls · Cited by 2
Managing Infective Endocarditis: What Lies Behind the High Mortality Rate and What Can We Do About it?
Cochrane, A. D., & Shi, W. Y. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2020.05.094 · Cited by 2
Pulmonary Valve Endocarditis during and beyond Euro ENDO Registry: A Single Center Case Series
Srdanović, I., Stefanović, M., Miljković, T., Bjelić, S., Trajković, M., Pantić, T., Velicki, L., & Milovančev, A. (2023) · Medicina · doi:10.3390/medicina59071213 · Cited by 1
Vacuum-Assisted Aspiration of Intracardiac Masses as a Bridge or Alternative to Surgery
Altermanini, M., Magdi, Y., Alzaeem, H. A., Maaly, C. A., Abdelghani, M., Al-Maraghi, S., Shouman, Y., Mohammad, N., & Al-Hijji, M. A. (2025) · JACC Case Reports · doi:10.1016/j.jaccas.2025.105095 · Cited by 1
Endocarditis: una patología para actuar con decisión
Velásquez, Ó. (2014) · Revista Colombiana de Cardiología · doi:10.1016/s0120-5633(14)70013-0 · Cited by 1
“El 80% de los casos de endocarditis son producidos por estreptococo y estafilococo, pero este último es ahora en muchos centros el organismo causal más frecuente (1, 2), de acu erdo con lo que reportan Eusse y colaboradores.”
Background
Infective endocarditis due to methicillin-sensitive Staphylococcus aureus in a patient with untreated atopic dermatitis who was successfully treated without surgery
Hibi, A., & Ito, C. (2018) · Oxford Medical Case Reports · doi:10.1093/omcr/omx113 · Cited by 1
Current Characteristics of Native Valve Infective Endocarditis in Japan
Kobayashi, D., Kuriyama, N., Takahashi, O., Hirano, K., Nanki, N., Arioka, H., Osugi, Y., & Yokota, K. (2018) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000689 · Cited by 1
Analysis of sleep characteristics and clinical outcomes of 139 adult patients with infective endocarditis after surgery
Hu, X., Lin, C.-D., Huang, D.-Y., Li, X., Lu, F., Wei, W., Yu, Z.-H., Liao, H.-S., Huang, F., Huang, X.-Z., et al. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i22.6319 · Cited by 1

Authors: Federspiel, J. J.
Affiliations: University of North Carolina at Chapel Hill (US)
Corresponding author: Federspiel, Jerome J.
ORCID: Federspiel, Jerome J.
Venue: Archives of Internal Medicine
Publisher: American Medical Association (AMA)
Published: 2012-02-27
Volume: 172
Issue: 4
Pages: 363
ISSN: 0003-9926 (ISSN-L)
DOI: 10.1001/archinternmed.2011.1027
PMC: PMC3314241
OpenAlex: W1980888902
Semantic Scholar: 6464b63aa9b09c73bae7ce57feb62961d940e702
Cited by: 129
References: 9
Citations by year: 2026: 2 · 2025: 4 · 2024: 5 · 2023: 8 · 2022: 7 · 2021: 8 · 2020: 14 · 2019: 10 · 2018: 18 · 2017: 10 · 2016: 14 · 2015: 10 · 2014: 7 · 2013: 10 · 2012: 2
FWCI: 6.94
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Archives of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: American Heart Association (0675027N)
Pfizer
GlaxoSmithKline
Vertex Pharmaceuticals
Medicines Company
Astellas Pharma
National Institutes of Health
University of North Carolina at Chapel Hill
National Institute on Aging (R01AG025801)
National Heart, Lung, and Blood Institute (F30HL110483)
National Institute of General Medical Sciences (T32GM008719)
National Institute of Allergy and Infectious Diseases (K24AI093969, R01AI068804)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
Keywords: infective endocarditis, Staphylococcus aureus, bacterial endocarditis, incidence, hospitalization rates, administrative data, United States
MeSH terms: Endocarditis, Bacterial, Hospitalization, Humans, Retrospective Studies, Staphylococcus aureus, United States, Incidence, Logistic Models

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increasing US Rates of <emph type="ital" /> Endocarditis With <emph type="ital">Staphylococcus aureus</emph>: 1999-2008

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks